Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 325

1.

Blood donor screening for parvovirus B19 in Germany and Austria.

Schmidt M, Themann A, Drexler C, Bayer M, Lanzer G, Menichetti E, Lechner S, Wessin D, Prokoph B, Allain JP, Seifried E, Hourfar MK.

Transfusion. 2007 Oct;47(10):1775-82.

PMID:
17714425
[PubMed - indexed for MEDLINE]
2.

Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.

Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP; National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study (REDS-II).

Transfusion. 2007 Oct;47(10):1756-64.

PMID:
17880600
[PubMed - indexed for MEDLINE]
3.

Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.

Thomas I, Di Giambattista M, Gérard C, Mathys E, Hougardy V, Latour B, Branckaert T, Laub R.

Vox Sang. 2003 May;84(4):300-7.

PMID:
12757504
[PubMed - indexed for MEDLINE]
4.
5.

Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction.

McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P.

J Clin Microbiol. 1993 Feb;31(2):323-8.

PMID:
8432819
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Parvovirus B19 transmission by a high-purity factor VIII concentrate.

Wu CG, Mason B, Jong J, Erdman D, McKernan L, Oakley M, Soucie M, Evatt B, Yu MY.

Transfusion. 2005 Jun;45(6):1003-10.

PMID:
15935000
[PubMed - indexed for MEDLINE]
7.

The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.

Ke L, He M, Li C, Liu Y, Gao L, Yao F, Li J, Bi X, Lv Y, Wang J, Hirsch ML, Li W.

Transfusion. 2011 Sep;51(9):1909-18. doi: 10.1111/j.1537-2995.2011.03067.x. Epub 2011 Mar 7.

PMID:
21382040
[PubMed - indexed for MEDLINE]
8.

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.

Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ; German Red Cross NAT Study Group.

Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.

PMID:
18466173
[PubMed - indexed for MEDLINE]
9.

Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.

Beersma MF, Claas EC, Sopaheluakan T, Kroes AC.

J Clin Virol. 2005 Sep;34(1):71-5.

PMID:
15985386
[PubMed - indexed for MEDLINE]
10.

Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.

Pichl L, Heitmann A, Herzog P, Oster J, Smets H, Schottstedt V.

Transfusion. 2005 Jul;45(7):1106-10.

PMID:
15987354
[PubMed - indexed for MEDLINE]
11.

Quantitative real-time detection of parvovirus B19 DNA in plasma.

Koppelman MH, Cuypers HT, Emrich T, Zaaijer HL.

Transfusion. 2004 Jan;44(1):97-103.

PMID:
14692974
[PubMed - indexed for MEDLINE]
12.

Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients.

Jordan J, Tiangco B, Kiss J, Koch W.

Vox Sang. 1998;75(2):97-102.

PMID:
9784661
[PubMed - indexed for MEDLINE]
13.

Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.

Geng Y, Wu CG, Bhattacharyya SP, Tan D, Guo ZP, Yu MY.

Transfusion. 2007 May;47(5):883-9.

PMID:
17465954
[PubMed - indexed for MEDLINE]
14.

[Safety of blood products and B19 parvovirus].

Lefrère JJ, Maniez-Montreuil M, Morel P, Defer C, Laperche S.

Transfus Clin Biol. 2006 Oct;13(4):235-41. Epub 2006 Jul 5. French.

PMID:
16822687
[PubMed - indexed for MEDLINE]
15.

Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.

Hourfar MK, Schmidt M, Seifried E, Roth WK.

Vox Sang. 2005 Aug;89(2):71-6.

PMID:
16101686
[PubMed - indexed for MEDLINE]
16.

Recipients potentially infected with parvovirus B19 by red blood cell products.

Hourfar MK, Mayr-Wohlfart U, Themann A, Sireis W, Seifried E, Schrezenmeier H, Schmidt M.

Transfusion. 2011 Jan;51(1):129-36. doi: 10.1111/j.1537-2995.2010.02780.x.

PMID:
20663115
[PubMed - indexed for MEDLINE]
17.

[Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].

Grabarczyk P, Korzeniowska J, Liszewski G, Kalińska A, Sulkowska E, Krug-Janiak M, Kopacz A, Łetowska M, Brojer E.

Przegl Epidemiol. 2012;66(1):7-12. Polish.

PMID:
22708291
[PubMed - indexed for MEDLINE]
18.
19.

High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation.

Weimer T, Streichert S, Watson C, Gröner A.

Transfusion. 2001 Dec;41(12):1500-4.

PMID:
11778063
[PubMed - indexed for MEDLINE]
20.

Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.

Sakata H, Matsubayashi K, Ihara H, Sato S, Kato T, Wakisaka A, Tadokoro K, Yu MY, Baylis SA, Ikeda H, Takamoto S.

Transfusion. 2013 Oct;53(10 Pt 2):2556-66. doi: 10.1111/j.1537-2995.2012.03949.x. Epub 2012 Nov 12.

PMID:
23145866
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk